| A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system A Dokoumetzidis, P Macheras International journal of pharmaceutics 321 (1-2), 1-11, 2006 | 758 | 2006 |
| On the use of the Weibull function for the discernment of drug release mechanisms V Papadopoulou, K Kosmidis, M Vlachou, P Macheras International journal of pharmaceutics 309 (1-2), 44-50, 2006 | 602 | 2006 |
| Modeling in biopharmaceutics, pharmacokinetics and pharmacodynamics: homogeneous and heterogeneous approaches P Macheras, A Iliadis Springer, 2016 | 226 | 2016 |
| Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio E Rinaki, G Valsami, P Macheras Pharmaceutical research 20 (12), 1917-1925, 2003 | 222 | 2003 |
| A reappraisal of drug release laws using Monte Carlo simulations: the prevalence of the Weibull function K Kosmidis, P Argyrakis, P Macheras Pharmaceutical research 20 (7), 988-995, 2003 | 208 | 2003 |
| In silico prediction of ADME and pharmacokinetics: Report of an expert meeting organised by COST B15 A Boobis, U Gundert-Remy, P Kremers, P Macheras, O Pelkonen European Journal of Pharmaceutical Sciences 17 (4-5), 183-193, 2002 | 177 | 2002 |
| Fractal kinetics in drug release from finite fractal matrices K Kosmidis, P Argyrakis, P Macheras The Journal of chemical physics 119 (12), 6373-6377, 2003 | 151 | 2003 |
| Fractional kinetics in drug absorption and disposition processes A Dokoumetzidis, P Macheras Journal of pharmacokinetics and pharmacodynamics 36 (2), 165-178, 2009 | 124 | 2009 |
| Analysis of dissolution data using modified versions of Noyes–Whitney equation and the Weibull function A Dokoumetzidis, V Papadopoulou, P Macheras Pharmaceutical research 23 (2), 256-261, 2006 | 122 | 2006 |
| On the heterogeneity of drug dissolution and release P Macheras, A Dokoumetzidis Pharmaceutical research 17 (2), 108-112, 2000 | 107 | 2000 |
| The power law can describe the ‘entire’drug release curve from HPMC-based matrix tablets: a hypothesis E Rinaki, G Valsami, P Macheras International journal of pharmaceutics 255 (1-2), 199-207, 2003 | 106 | 2003 |
| Fractional kinetics in multi-compartmental systems A Dokoumetzidis, R Magin, P Macheras Journal of pharmacokinetics and pharmacodynamics 37 (5), 507-524, 2010 | 102 | 2010 |
| A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms A Zajicek, MJ Fossler, JS Barrett, JH Worthington, R Ternik, G Charkoftaki, ... The AAPS journal 15 (4), 1072-1081, 2013 | 100 | 2013 |
| Identification of biowaivers among class II drugs: theoretical justification and practical examples E Rinaki, A Dokoumetzidis, G Valsami, P Macheras Pharmaceutical research 21 (9), 1567-1572, 2004 | 95 | 2004 |
| Analysis of Case II drug transport with radial and axial release from cylinders K Kosmidis, E Rinaki, P Argyrakis, P Macheras International journal of pharmaceutics 254 (2), 183-188, 2003 | 90 | 2003 |
| The mean dissolution time depends on the dose/solubility ratio E Rinaki, A Dokoumetzidis, P Macheras Pharmaceutical research 20 (3), 406-408, 2003 | 90 | 2003 |
| Gastrointestinal drug absorption: is it time to consider heterogeneity as well as homogeneity? P Macheras, P Argyrakis Pharmaceutical research 14 (7), 842-847, 1997 | 89 | 1997 |
| Biopharmaceutics of orally administered drugs P Macheras CRC Press, 1995 | 86 | 1995 |
| A commentary on fractionalization of multi-compartmental models A Dokoumetzidis, R Magin, P Macheras Journal of pharmacokinetics and pharmacodynamics 37 (2), 203-207, 2010 | 71 | 2010 |
| Bioavailability and bioequivalence: focus on physiological factors and variability V Karalis, P Macheras, A Van Peer, VP Shah Pharmaceutical research 25 (8), 1956-1962, 2008 | 68 | 2008 |
